Φορτώνει......
The anti-tumor effects of entinostat in ovarian cancer require adaptive immunity
BACKGROUND: Ovarian cancer is poorly immunogenic; however, increased major histocompatibility complex class II (MHCII) expression correlates with improved immune response and prolonged survival in ovarian cancer patients. We previously demonstrated that the histone deacetylase inhibitor entinostat i...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Cancer |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6294677/ https://ncbi.nlm.nih.gov/pubmed/30423192 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.31761 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|